rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
47
|
pubmed:dateCreated |
2008-10-16
|
pubmed:abstractText |
Cell cycle checkpoints and DNA repair act in concert to ensure DNA integrity during perturbation of normal replication or in response to genotoxic agents. Deficiencies in these protective mechanisms can lead to cellular transformation and ultimately tumorigenesis. Here we focused on Rev3, the catalytic subunit of the low-fidelity DNA repair polymerase zeta. Rev3 is believed to play a role in double-strand break (DSB)-induced DNA repair by homologous recombination. In line with this hypothesis, we show the accumulation of chromatin-bound Rev3 protein in late S-G2 of untreated cells and in response to clastogenic DNA damage as well as an gamma-H2AX accumulation in Rev3-depleted cells. Moreover, serine 995 of Rev3 is in vitro phosphorylated by the DSB-inducible checkpoint kinase, Chk2. Our data also disclose a significant reduction of rev3 gene expression in 74 colon carcinomas when compared to the normal adjacent tissues. This reduced expression is independent of the carcinoma stages, suggesting that the downregulation of rev3 might have occurred early during tumorigenesis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA polymerase zeta,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Directed DNA Polymerase,
http://linkedlifedata.com/resource/pubmed/chemical/H2AFX protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Histones,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/REV3L protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/checkpoint kinase 2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1476-5594
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
16
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6093-101
|
pubmed:dateRevised |
2011-11-2
|
pubmed:meshHeading |
pubmed-meshheading:18622427-Catalytic Domain,
pubmed-meshheading:18622427-Cells, Cultured,
pubmed-meshheading:18622427-Colonic Neoplasms,
pubmed-meshheading:18622427-DNA Breaks, Double-Stranded,
pubmed-meshheading:18622427-DNA Repair,
pubmed-meshheading:18622427-DNA Replication,
pubmed-meshheading:18622427-DNA-Binding Proteins,
pubmed-meshheading:18622427-DNA-Directed DNA Polymerase,
pubmed-meshheading:18622427-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18622427-Histones,
pubmed-meshheading:18622427-Humans,
pubmed-meshheading:18622427-Phosphorylation,
pubmed-meshheading:18622427-Protein-Serine-Threonine Kinases,
pubmed-meshheading:18622427-RNA, Messenger,
pubmed-meshheading:18622427-S Phase,
pubmed-meshheading:18622427-Tumor Suppressor Proteins
|
pubmed:year |
2008
|
pubmed:articleTitle |
Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta.
|
pubmed:affiliation |
Centre Régional de Cancérologie de Montpellier (INSERM-Université de Montpellier I Unité 868) Identité et Plasticité Tumorale, CRCM Val d'Aurelle-Lamarque, Montpellier cedex 5, France. jean-marc.brondello@inserm.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|